v3.25.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating activities:    
Net loss $ (3,624,443) $ (2,610,829)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of deferred compensation 13,962 18,938
Stock-based compensation expense 316,194 376,496
Depreciation and amortization expense 202,306 131,783
Amortization of discount on convertible notes 427,819
Changes in fair value of derivative liabilities 2,855,045
Changes in operating assets and liabilities:    
Change in accounts receivable (1,264,628) (3,753)
Change in prepaids and other current assets (114,670) (135,704)
Change in accounts payable (134,305) (298,974)
Change in accrued expenses and other current liabilities (9,496) 41,698
Net cash used in operating activities (1,332,216) (2,480,345)
Investing activities:    
Purchase of equipment (40,797) (164,290)
Net cash used in investing activities (40,797) (164,290)
Financing activities:    
Repurchase of common stock (4,001)
Proceeds from convertible notes issuance 3,145,000
Net cash provided by (used in) financing activities 3,145,000 (4,001)
Net change in cash 1,771,987 (2,648,636)
Cash, beginning of period 1,291,072 5,071,690
Cash, end of period $ 3,063,059 $ 2,423,054

Source